1. Exposure-response relationships of dapagliflozin on cardiorenal risk markers and adverse events: A pooled analysis of 13 phase II/III trials

   Koomen, J. V., Stevens, J. & Heerspink, H. J. L., 10-May-2020, In : British Journal of Clinical Pharmacology. 12 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteers

   Goulooze, S. C., Kruithof, A. C., Alikunju, S., Gautam, A., Burggraaf, J., Kamerling, I. M. C. & Stevens, J., 20-Apr-2020, In : British Journal of Clinical Pharmacology. 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Association between eight P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinemia

   Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Schmidt, A. F., Cohen, D., Boiko, A. S., Paderina, D. Z., Fedorenko, O. Y., Semke, A. V., Bokhan, N. A., Wilffert, B., Kosterink, J. G. W., Touw, D. J. & Loonen, A. J. M., 21-Mar-2020, In : British Journal of Clinical Pharmacology. 9 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Model informed quantification of the feed-forward stimulation of growth hormone by growth hormone releasing hormone

   van Esdonk, M. J., Burggraaf, J., van der Graaf, P. H. & Stevens, J., 22-Feb-2020, In : British Journal of Clinical Pharmacology. 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary

   Brouwers, J. R. B. J., van Lennep, J. E. R. & Beinema, M. J., Nov-2019, In : British Journal of Clinical Pharmacology. 85, 11, p. 2479-2486 8 p.

   Research output: Contribution to journal › Review article › Academic › peer-review

View all (149) »